Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, April 29, 2020
[ Wed, Apr 29th 2020
] - WOPRAI
[ Wed, Apr 29th 2020
] - WOPRAI
[ Wed, Apr 29th 2020
] - WOPRAI
[ Wed, Apr 29th 2020
] - WOPRAI
[ Wed, Apr 29th 2020
] - WOPRAI
Tue, April 28, 2020
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
Charles Duncan Maintained (AXSM) at Buy with Increased Target to $131 on, Apr 28th, 2020
Charles Duncan of Cantor Fitzgerald, Maintained "Axsome Therapeutics, Inc." (AXSM) at Buy with Increased Target from $125 to $131 on, Apr 28th, 2020.
Charles has made no other calls on AXSM in the last 4 months.
There is 1 other peer that has a rating on AXSM. Out of the 1 peers that are also analyzing AXSM, 0 agree with Charles's Rating of Hold.
This is the rating of the analyst that currently disagrees with Charles
- Joseph Thome of "Cowen & Co." Initiated at Buy and Held Target at $95 on, Tuesday, April 14th, 2020
